ENDOLOGIX INC /DE/ (ELGX) is a publicly traded company in the Unknown sector. Across all available filings, 46 corporate insiders have executed 869 transactions totaling $97.8M, demonstrating a bearish sentiment with -$85.2M in net insider flow. The most recent transaction on Sep 4, 2020 involved a sale of 33,709 shares valued at $1.7K.
No significant insider buying has been recorded for ELGX in the recent period.
No significant insider selling has been recorded for ELGX in the recent period.
Based on recent SEC filings, insider sentiment for ELGX is bearish with an Insider Alignment Score of 6/100 and a net flow of -$85.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ENDOLOGIX INC /DE/ (ELGX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 46 insiders are actively trading ELGX stock, having executed 869 transactions in the past 90 days. The most active insider is Woodlands Health Ventures Fund VII Lp Essex (Executive), who has made 6 transactions totaling $56.8M.
Get notified when executives and directors at ELGX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 4, 2020 | Lemaitre Dan | Executive | Sale | 33,709 | $0.05 | $1.7K | |
| Sep 4, 2020 | Lemaitre Dan | Executive | Sale | 15,553 | $0.05 | $778 | |
| Sep 4, 2020 | Lemaitre Dan | Executive | Sale | 2,582 | $0.05 | $129 | |
| Aug 14, 2020 | Lemaitre Dan | Executive | Sale | 1,127 | $0.08 | $90 | |
| Aug 13, 2020 | Lemaitre Dan | Executive | Sale | 1,126 | $0.09 | $101 | |
| Aug 12, 2020 | Buch Pinto Cynthia | Executive | Sale | 12,003 | $0.09 | $1.1K | |
| Aug 12, 2020 | Thompson Matthew | Executive | Sale | 21,888 | $0.09 | $2.0K | |
| Aug 12, 2020 | Wilder Thomas | Executive | Sale | 12,088 | $0.08 | $967 | |
| Aug 12, 2020 | Wilder Thomas | Executive | Sale | 15,776 | $0.08 | $1.3K | |
| Aug 12, 2020 | Nicholas Brady Timothy | Executive | Sale | 1,628 | $0.08 | $130 | |
| Aug 12, 2020 | Nicholas Brady Timothy | Executive | Sale | 113 | $0.09 | $10 | |
| Aug 12, 2020 | Onopchenko John | Executive | Sale | 57,415 | $0.88 | $50.5K | |
| Aug 12, 2020 | Onopchenko John | Executive | Sale | 1,306 | $0.09 | $118 | |
| Aug 12, 2020 | Onopchenko John | Executive | Sale | 30,257 | $0.08 | $2.4K | |
| Aug 12, 2020 | D. Waller Gregory | Executive | Sale | 28,630 | $0.08 | $2.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 297 | $91.5M | 75.2% |
Award(A) | 260 | $16.1M | 13.2% |
Purchase(P) | 172 | $6.3M | 5.2% |
Exercise(M) | 56 | $5.5M | 4.5% |
Payment(F) | 61 | $2.3M | 1.9% |
Disposition(D) | 13 | $32.3K | 0.0% |
Other(J) | 10 | $0 | 0.0% |
Insider selling pressure at ENDOLOGIX INC /DE/ has increased, with 46 insiders executing 869 transactions across all time. Total sales of $91.5M significantly outpace purchases of $6.3M, resulting in a net outflow of $85.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.